Streptococcus pyogenes Infections - Pipeline Review, H2 2018

Publisher Name :
Date: 17-Jul-2018
No. of pages: 36
Inquire Before Buying

Streptococcus pyogenes Infections - Pipeline Review, H2 2018

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Streptococcus pyogenes Infections - Pipeline Review, H2 2018, provides an overview of the Streptococcus pyogenes Infections (Infectious Disease) pipeline landscape.

Streptococcus pyogenes infections are caused by Streptococcus pyogenes, a spherical, Gram-positive bacterium. Symptoms include significant pain, swelling, and redness of infected area, fever, dizziness, difficulty breathing, dangerously low blood pressure, and a weak, rapid pulse. Treatment includes antibiotics and healthy lifestyle.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Streptococcus pyogenes Infections - Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for Streptococcus pyogenes Infections (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Streptococcus pyogenes Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Streptococcus pyogenes Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in IND/CTA Filed, Preclinical and Discovery stages are 1, 4 and 2 respectively. Similarly, the Universities portfolio in Phase I and Preclinical stages comprises 1 and 1 molecules, respectively.

Streptococcus pyogenes Infections (Infectious Disease) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Streptococcus pyogenes Infections (Infectious Disease).

- The pipeline guide reviews pipeline therapeutics for Streptococcus pyogenes Infections (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources.

- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.

- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

- The pipeline guide reviews key companies involved in Streptococcus pyogenes Infections (Infectious Disease) therapeutics and enlists all their major and minor projects.

- The pipeline guide evaluates Streptococcus pyogenes Infections (Infectious Disease) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.

- The pipeline guide reviews latest news related to pipeline therapeutics for Streptococcus pyogenes Infections (Infectious Disease)

Reasons to buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.

- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

- Find and recognize significant and varied types of therapeutics under development for Streptococcus pyogenes Infections (Infectious Disease).

- Classify potential new clients or partners in the target demographic.

- Develop tactical initiatives by understanding the focus areas of leading companies.

- Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.

- Formulate corrective measures for pipeline projects by understanding Streptococcus pyogenes Infections (Infectious Disease) pipeline depth and focus of Indication therapeutics.

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.

- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Streptococcus pyogenes Infections - Pipeline Review, H2 2018

Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Streptococcus pyogenes Infections - Overview
Streptococcus pyogenes Infections - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Streptococcus pyogenes Infections - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Streptococcus pyogenes Infections - Companies Involved in Therapeutics Development
Absynth Biologics Ltd
AstraZeneca Plc
Cadila Pharmaceuticals Ltd
Crestone Inc
Helix BioMedix Inc
Wellstat Vaccines LLC
Streptococcus pyogenes Infections - Drug Profiles
(mupirocin calcium + neomycin sulfate + HT-61) - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
AZ-6142 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
HB-1345 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules to Inhibit PolC for Gram-Positive Bacterial Infections - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Streptococcus [serotype A] vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
streptococcus pyogenes (30-valent) vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Streptococcus pyogenes vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Streptococcus pyogenes vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Streptococcus pyogenes vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Streptococcus pyogenes Infections - Dormant Projects
Streptococcus pyogenes Infections - Discontinued Products
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Number of Products under Development for Streptococcus pyogenes Infections, H2 2018
Number of Products under Development by Companies, H2 2018
Number of Products under Development by Universities/Institutes, H2 2018
Products under Development by Companies, H2 2018
Products under Development by Universities/Institutes, H2 2018
Number of Products by Stage and Target, H2 2018
Number of Products by Stage and Mechanism of Action, H2 2018
Number of Products by Stage and Route of Administration, H2 2018
Number of Products by Stage and Molecule Type, H2 2018
Streptococcus pyogenes Infections - Pipeline by Absynth Biologics Ltd, H2 2018
Streptococcus pyogenes Infections - Pipeline by AstraZeneca Plc, H2 2018
Streptococcus pyogenes Infections - Pipeline by Cadila Pharmaceuticals Ltd, H2 2018
Streptococcus pyogenes Infections - Pipeline by Crestone Inc, H2 2018
Streptococcus pyogenes Infections - Pipeline by Helix BioMedix Inc, H2 2018
Streptococcus pyogenes Infections - Pipeline by Wellstat Vaccines LLC, H2 2018
Streptococcus pyogenes Infections - Dormant Projects, H2 2018
Streptococcus pyogenes Infections - Discontinued Products, H2 2018

List of Figures
Number of Products under Development for Streptococcus pyogenes Infections, H2 2018
Number of Products under Development by Companies, H2 2018
Number of Products under Development by Universities/Institutes, H2 2018
Number of Products by Top 10 Targets, H2 2018
Number of Products by Stage and Top 10 Targets, H2 2018
Number of Products by Mechanism of Actions, H2 2018
Number of Products by Stage and Mechanism of Actions, H2 2018
Number of Products by Routes of Administration, H2 2018
Number of Products by Stage and Routes of Administration, H2 2018
Number of Products by Molecule Types, H2 2018
Number of Products by Stage and Molecule Types, H2 2018
  • 2018-2023 Global Metronidazole Consumption Market Report
    Published: 20-Aug-2018        Price: US 4660 Onwards        Pages: 163
    In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Metronidazole market for 2018-2023. Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvag......
  • Global and India Cephalosporin Market Research by Company, Type & Application 2013-2025
    Published: 17-Aug-2018        Price: US 2000 Onwards        Pages: 104
    Summary Cephalosporin is an antibiotic medication commonly prescribed to treat several different types of infections.Cephalosporin originally derived from the fungus Acremonium, which was previously known as ""Cephalosporium" Market Segment as follows: By Type - First Generation - Second Generation - Third Generation - Fourth Generation By Application - Oral - Injection By Company......
  • 2018-2023 Global Cephalosporin Consumption Market Report
    Published: 16-Aug-2018        Price: US 4660 Onwards        Pages: 175
    In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Cephalosporin market for 2018-2023. Cephalosporin is an antibiotic medication commonly prescribed to treat several different types of infections. The classification of Cephalosporin includes First Generation, Second Generation, Third Generation, Fourth Generation and the proportion of Third Generation in 2016 is about 37.2%, and the proportion is in ......
  • 2018-2023 India Drugs for Herpes Labialis (Oral Herpes) Market Report (Status and Outlook)
    Published: 16-Aug-2018        Price: US 3360 Onwards        Pages: 86
    In 2017, the Drugs for Herpes Labialis (Oral Herpes) market size was xx million USD in India, and it will be xx million USD in 2023, with a CAGR of xx% between 2017 and 2023. In India market, the top players include - GSK - Novartis - Teva - Mylan - Cadila - Apotex - Daewoong Pharmaceutical - Livzon - Luoxin - Med shine - Bayer (Campho Phenique) - Blistex - Kelun Group - Hikma ......
  • 2018-2023 Philippines Drugs for Herpes Labialis (Oral Herpes) Market Report (Status and Outlook)
    Published: 16-Aug-2018        Price: US 3360 Onwards        Pages: 86
    In 2017, the Drugs for Herpes Labialis (Oral Herpes) market size was xx million USD in Philippines, and it will be xx million USD in 2023, with a CAGR of xx% between 2017 and 2023. In Philippines market, the top players include - GSK - Novartis - Teva - Mylan - Cadila - Apotex - Daewoong Pharmaceutical - Livzon - Luoxin - Med shine - Bayer (Campho Phenique) - Blistex - Kelun Group - H......
  • 2018-2023 UK Drugs for Herpes Labialis (Oral Herpes) Market Report (Status and Outlook)
    Published: 16-Aug-2018        Price: US 3360 Onwards        Pages: 86
    In 2017, the Drugs for Herpes Labialis (Oral Herpes) market size was xx million USD in UK, and it will be xx million USD in 2023, with a CAGR of xx% between 2017 and 2023. In UK market, the top players include - GSK - Novartis - Teva - Mylan - Cadila - Apotex - Daewoong Pharmaceutical - Livzon - Luoxin - Med shine - Bayer (Campho Phenique) - Blistex - Kelun Group - Hikma - Haiw......
  • 2018-2023 United States Drugs for Herpes Labialis (Oral Herpes) Market Report (Status and Outlook)
    Published: 16-Aug-2018        Price: US 3360 Onwards        Pages: 86
    In 2017, the Drugs for Herpes Labialis (Oral Herpes) market size was xx million USD in United States, and it will be xx million USD in 2023, with a CAGR of xx% between 2017 and 2023. In United States market, the top players include - GSK - Novartis - Teva - Mylan - Cadila - Apotex - Daewoong Pharmaceutical - Livzon - Luoxin - Med shine - Bayer (Campho Phenique) - Blistex - Kelun Group ......
  • Global Metronidazole Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 10-Aug-2018        Price: US 3480 Onwards        Pages: 147
    Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc. Scope of the Report: This report focuses on the Metronidazole in global market, especially in North America, Europe and Asia-......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Metronidazole Market 2018, Forecast to 2023
    Published: 10-Aug-2018        Price: US 4880 Onwards        Pages: 146
    Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc. Scope of the Report: This report focuses on the Metronidazole in global market, especially in North America, Europe and Asia-......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs